Syngene

Syngene International, founded in 1993 and operating under the ticker NSE: SYNGENE, is a leading Business Services organization headquartered in India. As a comprehensive contract research and manufacturing organization (CRO/CDMO), Syngene delivers end-to-end discovery and development services. The company supports pharmaceutical, biotechnology, nutrition, cosmetic, and specialty healthcare sectors by providing integrated solutions from early-stage research to commercial manufacturing. Its commitment to scientific rigor and client collaboration underpins its role as a vital partner in global life sciences innovation.

Employing a workforce of 5,000-10,000 individuals, Syngene possesses extensive capabilities in medicinal chemistry, biology, toxicology, process R&D, and custom synthesis. The organization is equipped to handle complex projects, offering a broad spectrum of services designed to accelerate client pipelines. Meet Syngene's team to discover the expertise driving its advanced scientific operations and project execution.

Syngene's product and service offerings include cGMP manufacturing and formulation development, alongside analytical services and pharmacovigilance. With a reported revenue of $400.8M, the company demonstrates significant operational scale and market presence. Its strategic focus on innovation and integrated service delivery across the value chain solidifies its position as a key player in the contract research and manufacturing landscape.